Salarius Pharmaceuticals Inc. buy melinda
Start price
12.06.17
/
50%
€51,442
Target price
21.06.17
€57,784
Performance (%)
14.25%
End price
21.06.17
€58,771
Summary
This prediction ended on 21.06.17 with a price of €58,771. The prediction had a final performance of 14.25%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49,892
15.04.17
15.04.17
€57,784
27.04.17
27.04.17
9.04%
27.04.17
27.04.17
